They may still need another cap raise at some point in the...

They may still need another cap raise at some point in the future as they arent cash flow positive yet and if they do receive their medicinal cannabis licences in aus then they'll be outlaying more money than they are now to get it all up and running. That's not to say they're not doing well though, i quite like them also, but atm they cant really be compared with ac8 and can etc as they're not in the same industry... yet.
Exl are hemp foods and over the counter cbd products derived from industrial hemp in the US and they are killing it there. But its not the same as the clinical trial, product registration, pbs, medicinal cannabis path.

No doubt they'll receive their aus licences tomorrow morning and this will are be meaningless haha But I reckon your judging the other companies a bit harshly. They've done whats seeming to be the hardest bit.. actually getting the licences. The fact that every single cannabis cultivation and or manufacturing company seem to be going at snails pace, id say its more the poorly structured australian system they are having to deal with atm rather than them needing to get their act together. I guess thats just all part of being the the first movers in a new industry, exciting times for all!